These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10648407)

  • 1. Proteolytic processing of human coagulation factor IX by plasmin.
    Samis JA; Ramsey GD; Walker JB; Nesheim ME; Giles AR
    Blood; 2000 Feb; 95(3):943-51. PubMed ID: 10648407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
    Samis JA; Kam E; Nesheim ME; Giles AR
    Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer.
    Schmidt AE; Vadivel K; Whitelegge J; Bajaj SP
    J Thromb Haemost; 2020 May; 18(5):1171-1182. PubMed ID: 32073726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative interactions of factor IX and factor IXa with human platelets.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation.
    Lawson JH; Mann KG
    J Biol Chem; 1991 Jun; 266(17):11317-27. PubMed ID: 2040636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors.
    Hsu YC; Hamaguchi N; Chang YJ; Lin SW
    Biochemistry; 2001 Sep; 40(37):11261-9. PubMed ID: 11551226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage and inactivation of Factor IX by granulocyte elastase.
    Takaki A; Enfield DL; Thompson AR
    J Clin Invest; 1983 Nov; 72(5):1706-15. PubMed ID: 6605369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.
    Lollar P; Parker CG; Kajenski PJ; Litwiller RD; Fass DN
    Biochemistry; 1987 Dec; 26(24):7627-36. PubMed ID: 3322404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.
    Lollar P; Knutson GJ; Fass DN
    Blood; 1984 Jun; 63(6):1303-8. PubMed ID: 6426549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain.
    Nogami K; Nishiya K; Saenko EL; Takeyama M; Tanaka I; Yoshioka A; Shima M
    Biochim Biophys Acta; 2008 May; 1784(5):753-63. PubMed ID: 18329389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone.
    Lollar P; Fass DN
    Arch Biochem Biophys; 1984 Sep; 233(2):438-46. PubMed ID: 6435527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.